[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100628234":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":34,"centralContacts":38,"locations":48,"responsibleParty":64,"collaborators":67,"id":68,"slug":67,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":73,"eligibilityCriteria":74,"healthyVolunteers":69,"sex":75,"minAge":76,"maxAge":67,"enrollmentInfo":77,"targetDuration":67,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":86,"overallStatus":51,"whyStopped":67,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Helsinki University Central Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients receiving active treatment","EXPERIMENTAL","CDI patients receiving healthy donor stool by capsules",[13],"Biological: Healthy donor stool",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo arm","PLACEBO_COMPARATOR","Placebo FMT capsules",[19],"Biological: placebo capsule",[21,29],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"BIOLOGICAL","Healthy donor stool","Healthy donor stool given by capsules produced by the same method as in Copenhagen University Hospital",[9],[27,28],"Fecal microbiota transplantation","FMT",{"type":22,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"placebo capsule","Copenhagen University Hvidrovre Hospital method for capsule production",[15],[17],[35],{"name":36,"affiliation":5,"role":37},"Perttu Arkkila, Professor","PRINCIPAL_INVESTIGATOR",[39,44],{"name":36,"role":40,"phone":41,"phoneExt":42,"email":43},"CONTACT","+358504272272","+35894711","perttu.arkkila@hus.fi",{"name":45,"role":40,"phone":46,"phoneExt":42,"email":47},"Suvi Niku, PhD, MD","+35840 7579938","suvi.niku@hus.fi",[49],{"facility":50,"status":51,"city":52,"state":53,"zip":54,"country":55,"cosmosGeoPoint":56,"geoPoint":61,"contacts":62},"Helsinki University Hospital","RECRUITING","Helsinki","Uusimaa","00290","Finland",{"type":57,"coordinates":58},"Point",[59,60],24.93545,60.16952,{"lat":60,"lon":59},[63],{"name":36,"role":40,"phone":41,"phoneExt":42,"email":43},{"type":37,"investigatorFullName":65,"investigatorTitle":66,"investigatorAffiliation":5,"oldNameTitle":67,"oldOrganization":67},"Perttu Arkkila","Professor",null,"100628234",false,"NCT07458984","FMT Capsules for rCDI","Fecal Microbiota (FMT) Oral Capsules in the Treatment of Recurrent Clostridioides Difficile Infection","FMT CAP CDI","Inclusion Criteria:\n\n* At least twice recurrent CDI\\*\n* Patient has had CDI-related diarrhea during infections (3 or more Bristol Stool Form Scale type 6-7 stools)\n* Other causes of diarrhea have been excluded based on clinical data\n* Age over 18 years\n* Remission of symptoms during antibiotic course (metronidazole, vancomycin or fidaxomicin)\n* No other antibiotic courses\n* Able to sign the consent form or accept it electronically via Suomi.fi identification\n\n  * definition of recurrent CDI: CDI-compatible symptoms and a positive stool test Clostridioides difficile nucleic acid test within 12 weeks of the previous infection\n\nExclusion Criteria:\n\n* Pregnancy\n* Continuous need for antibiotic treatment\n* Previous anaphylactic reactions to any food\n* Gastroparesis\n* Life-threatening fulminant CDI\n* Life expectancy less than 1 year\n* Inability to sign a consent form for the study","ALL","18 Years",{"count":78,"type":79},76,"ESTIMATED","INTERVENTIONAL",[82],"PHASE3","Double blind RCT study of tretment of recurrent Clostridioides difficile infection by FMT capsules.",[85,28],"Clostridioides Difficile Infection Recurrence",[87,28,88],"Clostridioides Difficile infection","Capsule","2026-04-24",{"date":91,"type":92},"2026-04-29","ACTUAL",{"date":94,"type":92},"2026-04-25",{"date":96,"type":79},"2030-12-31",{"name":5,"class":6},1]